Complete profile


Third-Party Information Liability Disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.




Last Updated: 2013-04-18

Ergoresearch

Company information

Logo  
 
Legal Name:   Ergoresearch
Operating Name:   Ergoresearch
 
Mailing Address
200-2101 Le Carrefour Blvd
LAVAL, Quebec
H7S 2J7
Location Address
200-2101 Le Carrefour Blvd
LAVAL, Quebec
H7S 2J7
 
Telephone: (450) 973-6700
Toll Free Phone: 1-877-785-7433
Fax: (450) 973-1624
Email: info@ergoresearch.com
Website URL: http://www.ergoresearch.com/en/ 
 
Top

Contact information

 
Sylvain Boucher
  Title:   Chief Executive Officer
  Area of Responsibility:   Government Relations
  Telephone:   (450) 973-6700
  Ext:   213
  Fax:   (450) 973-1624
  Email:   sboucher@ergoresearch.com
 
 
Frédéric Petit
  Title:   Vice President
  Area of Responsibility:   Management Executive
  Telephone:   (418) 688-7433
  Fax:   (450) 973-1624
  Email:   fpetit@ergoresearch.com
 
 
Louis Desrosiers
  Title:   Vice President
  Area of Responsibility:   Research/Development/Engineering
  Telephone:   (418) 564-1794
  Fax:   (450) 973-1624
  Email:   ldesrosiers@ergoresearch.com
 

Top

Company description

 
Ergoresearch has developed the most important network of orthotics clinics in Québec, with over one hundred clinics and satellite centres flying under the banners of Clinique du pied Équilibre, Orthoconcept, Podotech and Laboratoire Langelier. Québec’s leading manufacturer of "intelligent" foot orthotics and specialty orthotics, it is a trend-setter in creating durable medical equipment and software for the orthopedics market.

Ergoresearch has developed and commercialized Expert-Fit™, the first robotized custom-fit orthotics manufacturing software program, launched the first Living Lab in Canada and more recently, a new generation of world-patented orthotic device called the OdrA, that revolutionizes the treatment of pain associated with knee osteoarthritis.

The company is involved in many important research projects with institutions such as Université Laval and Collège Mérici’s Centre de solutions technologiques en orthèses et prothèses (CSTOP), in Quebec City. Ergoresearch Ltd is listed on the Toronto Stock Exchange (TSXV) under the Symbol: ERG.  
Country of Ownership: Canada  
Year Established: 2000
Exporting: Yes  
Primary Industry (NAICS): 339110 - Medical Equipment and Supplies Manufacturing
Alternate Industries (NAICS): 541510 - Computer Systems Design and Related Services
541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer  
Total Sales ($CDN): $5,000,000 to $9,999,999 
Export Sales ($CDN): $200,000 to $499,999 
Number of Employees: 83 

Top

Product / Service / Licensing

 
Product Name: ERGO-STATION 2000
 
Motion analysis software management tool.

 
Product Name: EXPERT-FIT/WEB-FIT System
 
Ergoresearch’s unique custom-fit foot orthotic design system relies on patented technology. With its podo-sensor pad and scanner, Expert-Fit / Web-Fit reads the foot’s pressure points during assessment and based on these results, generates the optimal foot surface design using artificial intelligence.

Thanks to unique computer-aided design software (CAD), a three-dimensional imprint is transmitted via the Ergoresearch computational server. Then, using computer-aided manufacturing software (CAM) and numerical control machine tools (NCMT), it offers the ability to produce the optimal custom-fit orthotic device for each patient. The robotics manufacturing process enables made-to-measure orthotic devices to be mass produced, while ensuring state of the art precision, comfort and biomechanical efficacy.

 
Product Name: OdrA Knee Brace
 
OdrA is a new generation of orthotics launched exclusively on Canadian markets by Ergoresearch. The name OdrA – French acronym for Orthèse de Distraction et Rotation pour Arthrose – summarizes how it works: OA distraction–rotation orthotic device. Its unique, world-patented mechanism is designed to provide rapid, efficient pain relief to knee OA sufferers.

By combining a slight external rotation of the foot with a distraction, which is when the space between the tibia and the femur is extended, the mechanism decreases the weight on the medial knee compartment, thereby lessening pain and providing the joint with greater mobility.

 
Product Name: Seat simulator EXPERT SEAT
 
Description Seat simulator for the evaluation and fabrication (CAM) of custom-built cushions for wheelchairs and other seats
for the aeronautic and automotive industries. This measurement system is linked with a CNC tool machine which permits the
fabrication of custom-built cushions.

 

Top

Market profile

Alliances:

  • Sales/Marketing

Strategic alliances:

Ergoresearch's growth strategy is mainly orchestrated around acquisitions or partnerships.

•The acquisition of orthopedic prescription laboratories represents a significant percentage of business revenue, generated through the sale of custom-fit foot orthotics. While Ergoresearch’s efforts began in Quebec and spread across Canada, they now include a full North-American market. The implementation of the Ergoresearch concept has brought about important strategic advantages, merchandise price cuts and a substantial increase in revenues. Vertical integration and staked shareholder control has enabled the company to deploy its innovations in a controlled environment, and therefore ensure the reproduction of optimal impacts in respect with the firm’s ownership policies.

•Organic growth is supported by sturdy clinical and marketing toolboxes and a full network of healthcare professionals. Mobile Internet tools enable the company to offer services at what are known as ‘satellite’ medical clinics and meet patients in person, at the clinic of their choice. Such strategies ensure an increase in client visits and in domestic market shares.

International markets are approached via a full range of business opportunities. Ergoresearch’s directors do not hesitate to adapt their business model and strategies for infiltrating a new market once they have come to terms with its specificities. On the American market for instance, where the legal environment is very hostile to this type of acquisition, the company has no plans to acquire a network of clinics. It has been determined instead that an Ergoresearch product launch would take place on a manufacturing platform.
Top



Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.